Search Results - "Usadi, Rebecca"

Refine Results
  1. 1

    On-label and off-label drug use in the treatment of female infertility by Usadi, Rebecca S., M.D, Merriam, Kathryn S., B.A

    Published in Fertility and sterility (01-03-2015)
    “…Female infertility affects millions of couples worldwide and is estimated to account for one-third of all cases of infertility. The purpose of this article is…”
    Get full text
    Journal Article
  2. 2

    Influence of ejaculatory abstinence on seminal total antioxidant capacity and sperm membrane lipid peroxidation by Marshburn, Paul B., M.D, Giddings, Allie, M.D, Causby, Stephanie, M.S, Matthews, Michelle L., M.D, Usadi, Rebecca S., M.D, Steuerwald, Nury, Ph.D, Hurst, Bradley S., M.D

    Published in Fertility and sterility (01-09-2014)
    “…Objective To determine whether the period of ejaculatory abstinence (EA) influences the total antioxidant capacity (TAC) of semen or lipid peroxidation (LPO)…”
    Get full text
    Journal Article
  3. 3

    Subclinical Hypothyroidism: Impact on Fertility, Obstetric and Neonatal Outcomes by Usadi, Rebecca S, Merriam, Kathryn S

    Published in Seminars in reproductive medicine (01-11-2016)
    “…The incidence of subclinical hypothyroidism (SCH) in pregnancy was classically thought to be low; however, with new definition of normal TSH range in…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Androgenicity and fertility treatment in women with unexplained infertility by Wang, Erica T., Diamond, Michael P., Alvero, Ruben, Casson, Peter, Christman, Gregory M., Coutifaris, Christos, Hansen, Karl R., Sun, Fangbai, Legro, Richard S., Robinson, Randal D., Usadi, Rebecca S., Pisarska, Margareta D., Santoro, Nanette F., Zhang, Heping

    Published in Fertility and sterility (01-03-2020)
    “…To determine whether biochemical or clinical markers of androgenic activity predict live birth rate with ovarian stimulation in the unexplained infertility…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Association of blood type and patient characteristics with ovarian reserve by Timberlake, Kathryn S., B.S, Foley, Kristie L., Ph.D, Hurst, Bradley S., M.D, Matthews, Michelle L., M.D, Usadi, Rebecca S., M.D, Marshburn, Paul B., M.D

    Published in Fertility and sterility (01-12-2013)
    “…Objective To assess whether blood type was associated with diminished ovarian reserve (DOR) (day-3 follicle-stimulating hormone level >10 IU/L), controlling…”
    Get full text
    Journal Article
  8. 8

    Endocrine and Reproductive Effects of Polycystic Ovarian Syndrome by Ecklund, Laura C., MD, Usadi, Rebecca S., MD

    “…Management strategies for overweight and obese women with polycystic ovarian syndrome (PCOS) who desire fertility should include weight loss. Even a small…”
    Get full text
    Journal Article
  9. 9

    Obstetric and Gynecologic Challenges in Women With Ehlers-Danlos Syndrome by Hurst, Bradley S., Lange, Sara S., Kullstam, Susan M., Usadi, Rebecca S., Matthews, Michelle L., Marshburn, Paul B., Templin, Megan A., Merriam, Kathryn S.

    Published in Obstetrics and gynecology (New York. 1953) (01-03-2014)
    “…To determine how often women with Ehlers-Danlos syndrome experience obstetric and gynecologic issues both compared with the general population and within the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Reproductive impact of polycystic ovary syndrome by Usadi, Rebecca S., Legro, Richard S.

    “…The purpose of this review is to highlight the impact of polycystic ovary syndrome (PCOS) on menstrual function, fertility and reproductive outcomes. Women…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Endometrial Development and Function in Experimentally Induced Luteal Phase Deficiency by Usadi, Rebecca S., Groll, Jeremy M., Lessey, Bruce A., Lininger, Ruth A., Zaino, Richard J., Fritz, Marc A., Young, Steven L.

    “…Context: It is generally assumed that delayed endometrial development observed in luteal phase deficiency (LPD) is the result of abnormally low progesterone…”
    Get full text
    Journal Article
  18. 18

    The effect of ketorolac on pregnancy rates when used immediately after oocyte retrieval by Mesen, Tolga B., M.D, Kacemi-Bourhim, Lamya, M.D, Marshburn, Paul B., M.D, Usadi, Rebecca S., M.D, Matthews, Michelle, M.D, Norton, H. James, Ph.D, Hurst, Bradley S., M.D

    Published in Fertility and sterility (01-09-2013)
    “…Objective To study the effect of ketorolac, a potent anti-inflammatory medication, on in vitro fertilization (IVF) pregnancy outcomes when used at the time of…”
    Get full text
    Journal Article
  19. 19

    Sexual Absorption of Vaginal Progesterone: A Randomized Control Trial by Usadi, Rebecca S., Matthews, Michelle L., Elliot, Mollie, Leake, Kristina A., Merriam, Kathryn S., Hurst, Bradley S.

    Published in International Journal of Endocrinology (01-01-2015)
    “…Objective. To determine if sexual intercourse reduces absorption of vaginal progesterone gel in women and to determine if progesterone is absorbed by the male…”
    Get full text
    Journal Article
  20. 20

    A short period of ejaculatory abstinence before intrauterine insemination is associated with higher pregnancy rates by Marshburn, Paul B., M.D, Alanis, Mark, M.D, Matthews, Michelle L., M.D, Usadi, Rebecca, M.D, Papadakis, Margaret H., Ph.D, Kullstam, Susan, M.S, Hurst, Bradley S., M.D

    Published in Fertility and sterility (2010)
    “…An ejaculatory abstinence period of ≤2 days before IUI produced the highest pregnancy rates per cycle compared with longer intervals of ejaculatory abstinence…”
    Get full text
    Journal Article